›› Rx Celebs Company News ›› Rx Celebs Campaign News ›› Rx Industry News ›› Rx Screening Room  Speakers Bureau   Medical Marketing & Media ›› Johns Hopkins to ban gifts, drug samples ›› Pfizer R&D to split into large and small molecule divisions ›› DDMAC raps sponsored links for omission of risk info ›› Brennan to chair PhRMA board, with Kindler waiting in the wings ›› Stanford to disclose faculty payments over $5K ›› Payers exert increasing influence on brand sales: Wolters Kluwer Health ›› Associations should cut ties with pharma, says JAMA ›› GSK to co-promote Shire's Vyvanse ›› Rite Aid promo offers free generic script   Read More     PRWeek ›› CDC launches new AIDS awareness initiative ›› MTV, Planned Parenthood collaborate on STD awareness ›› Global M&As post worst Q1 results in six years, mergermarket finds ›› May Institute shows the faces of autism to boost awareness May Institute shows the faces of autism to boost awareness ›› 23andMe reaches out to mommy bloggers   Read More     Medical News Today ›› Coartem® Receives FDA Approval Becoming First Artemisinin-based Combination Treatment (ACT) For Malaria In The US ›› AstraZeneca Receives FDA Complete Response Letter On Symbicort For The Treatment Of Asthma In Children 6 To 11 Years Old ›› Update On FDA Advisory Committee Meeting On Liraglutide For The Treatment Of Type 2 Diabetes ›› FDA Advisory Committee Provides Opinion On Serdolect® For The Treatment Of Schizophrenia   Read More     Phrma News ›› PPA Celebrates Fourth Anniversary Has Helped More Than 5.7 Million Uninsured Patients ›› PhRMA Honors Gardasil Researchers with Discoverers Award ›› David Brennan Elected PhRMA Board Chairman ›› Budget Conferees Should Pursue Regular Order Process for Health Care Reform ›› PhRMA Statement on Industry Support of Medical Associations   Read More     The Pink Sheet ›› Type 2 Diabetes Developers Take Heart: New Safety Hurdle Is Surmountable ›› Steve Nissen's Take On The Saxagliptin Review ›› Saxagliptin Cardiovascular Safety Affirmed, But Is It Approvable...And When? ›› Post-Marketing Trial Key To Saxagliptin Approval - And Commercial Potential ›› Liraglutide's Future Uncertain: Panel Voices Concern Over Cancer And CV Risk ›› Avastin Clinical Benefit Trumps Anti-Tumor Effect In Glioblastoma, ODAC Says ›› Avastin Needs Quality Of Life Data In Confirmatory Glioblastoma Trial - Cmte.   Read More     Pharma Marketing News ›› Syndication is da Bomb! ›› Pharma's Bad Rep or Bad Rap ›› Will Healthcare be Rationed or Rational? ›› FDA's Use of Social Media ›› New Privacy Rules in Economic Stimulus Law   Read More     Pharmaceutical Industry News ›› Skin cancer greatest threat for young women ›› Antiplatelet heart drug launched ›› FDA warns pharma over misleading web ads ›› Bodnar pleads guilty in BMS case ›› US health insurers investigated ›› AZ's Symbicort suffers setback ›› Pharma stocks hold steady ›› New blueprint for people with autism ›› Twenty-one NHS Trusts fail hygiene test ›› Government creates Office for Life Sciences   Read More       Medworm ›› Syndication is da Bomb!email this article ›› New Privacy Rules in Economic Stimulus Lawemail this article ›› FDA's Use of Social Mediaemail this article ›› Will Healthcare be Rationed or Rational?email this article ›› Pharma's Bad Rep or Bad Rapemail this article save this article to My Clippings ›› Pledge to Subscribers & Advertisersemail this article ›› Sales Force Effectiveness Metricsemail this article ›› The New Rules of Marketing & PRemail this article ›› Building the Optimal Service Modelemail this article   Read More     Medworm ›› Lilly prices new clot-buster at 31% premium ›› Traders talk up Sanofi-Biogen deal ›› Brown's psych chair is latest to step aside ›› Wyeth execs get big roles in new Pfizer ›› J&J says 'not now' on biosimilars ›› Branded meds suffer two times over ›› Pfizer's Nigerian deal held up by logistics ›› Another job for FDA: Online marketing regs ›› Melnyk: Crash chaos led to misreported financials ›› Sanofi in yet another emerging-market buyout   Read More     Reuters ›› HIV treatment should start earlier: experts ›› New malaria drug fights resistance ›› U.S. experts argue for tax on sweet drinks ›› "Brown fat" may help adults lose weight ›› U.S. FDA demands data on older medical devices ›› Sports may ease activity decline during teen years ›› Lung patients benefit from nutrition advice ›› Caffeine may lessen exercisers' muscle pain ›› FDA pressures New Jersey company to recall peanuts ›› Very obese adults almost completely sedentary   Read More     Forbes.com ›› FDA Faces Tough Choice On New Diabetes Drug ›› Pfizer Finalizing Settlement In Nigerian Drug Suit ›› Health Care Home Invasion ›› Attack Of The Zombie Biotechs ›› Pfizer Drug Fails In Breast Cancer Study   Read More     The Newyork Times ›› Calorie-Burning Fat? Studies Say You Have It ›› New Yorkers Often Exposed to Cigarette Smoke, Study Finds ›› House Dust Yields Clue to Asthma: Roaches ›› DNA Test Outperforms Pap Smear ›› Radiologist Adds a Human Touch: Photos ›› Vital Signs: Regimens: Tai Chi Shows Promise as a Stroke Therapy ›› Brain Power: Brain Researchers Open Door to Editing Memory ›› Heart Muscle Renewed Over Lifetime, Study Finds ›› Autism Rates Are Higher for U.S.-Born Somali Children in Minneapolis ›› Researchers Square Off on Disclosure   Read More     Pharmaceutical Executive ›› Gilead Buys CV Therapeutics ›› Rosche and Genentech Seal the Deal for $46.8 Billion ›› Merck Takes Unusual Merger Tactic in Schering Deal ›› Genentech and Rosche May Be Close to Deal ›› Astellas to Nominate Two Directors to CV Therapeutics Board ›› Pharma Companies Hit With Warnings for Search Marketing ›› Putting Predictive Market Research to the Test ›› Heart Muscle Renewed Over Lifetime, Study Finds ›› Shire Joins with GSK to Promote ADHD Drug ›› Fixing Pfizer's Rep: An Interview with Kathryn Metcalfe ›› Pharma Media Spend Falls 18.4 Percent   Read More

© 2009 Rx Celebs, LLC